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Abstract 
The aim of this study was to characterize
the in vitro osteogenic differentiation of den-
tal pulp stem cells (DPSCs) in 2D cultures and
3D biomaterials. DPSCs, separated from den-
tal pulp by enzymatic digestion, and isolated by
magnetic  cell  sorting  were  differentiated
toward osteogenic lineage on 2D surface by
using an osteogenic medium. During differen-
tiation process, DPSCs express specific bone
proteins like Runx-2, Osx, OPN and OCN with
a  sequential  expression,  analogous  to  those
occurring  during  osteoblast  differentiation,
and produce extracellular calcium deposits. In
order to differentiate cells in a 3D space that
mimes the physiological environment, DPSCs
were  cultured  in  two  distinct  bioscaffolds,
Matrigel™  and  Collagen  sponge.  With  the
addition of a third dimension, osteogenic dif-
ferentiation  and  mineralized  extracellular
matrix  production  significantly  improved.  In
particular, in Matrigel™ DPSCs differentiated
with  osteoblast/osteocyte  characteristics  and
connected  by  gap  junction,  and  therefore
formed calcified nodules with a 3D intercellu-
lar network. Furthermore, DPSCs differentiat-
ed in collagen sponge actively secrete human
type I collagen micro-fibrils and form calcified
matrix  containing  trabecular-like  structures.
These neo-formed DPSCs-scaffold devices may
be used in regenerative surgical applications
in order to resolve pathologies and traumas
characterized by critical size bone defects.
Introduction
Adult stem cells have been isolated from a
variety of human differentiated tissues such
as skin, muscle, adipose tissue, bone marrow
or blood. It was generally accepted that the dif-
ferentiation potential of these stem cells was
restricted to generate cells of the origin line-
age.  Recently  different  authors  demonstrate
that adult stem cells show a multilineage dif-
ferentiation potential.
1 
Dental pulp stem cells (DPSCs) represent
an adult stem cells population originating from
neural crest cells that reside in the perivascu-
lar niche of dental pulp and constitute a source
of stem cells easily recruitable with low inva-
sivity for the patient.
2,3 DPSCs are multipotent
cells  that  typically  express  the  STRO-1  and
CD146 antigens and are able to differentiate
in  osteogenic,  chondrogenic,  myogenic,  adi-
pogenic and neurogenic lineage according to
their embryonic origin.
4,5 A c-Kit
+/CD34
+/STRO-
1
+ DPSC multipotent sub-population, particu-
larly able to differentiate in osteogenic line-
age,  named  SBP-DPSCs,  was  isolated  from
DPSCs by flow cytometry. Osteogenic differen-
tiated SBP-DPSCs express bone tissue specific
proteins, produce calcified extracellular matrix
(ECM) and form nodular cell aggregates and
nodular bone in vitro.
6-8
Osteoblast differentiation occurs at differ-
ent stages: it starts with the commitment of
mesenchimal  cells  (MC)  in  osteoprogenitor
cells  that  differentiate  in  immature  osteo  -
blasts and then in mature osteoblasts. Specific
transcription factors induce MC to acquire the
osteoblast phenotype and promote the expres-
sion of proteins typical of bone tissue. Runx2
is  considered  the  major  transcription  factor
controlling  osteoblast  differentiation.  It  is
expressed by MC throughout their osteogenic
differentiation, and is also present in mature
osteoblasts.  Osterix  (Osx)  is  a  zinc  finger
transcription factor essential to osteoblast dif-
ferentiation,  acting  downstream  Runx2,  and
modulating  the  expression  of  important
osteoblast  proteins  such  as  osteopontin
(OPN), osteocalcin (OCN), bone sialoprotein
and collagen type I.
9-11 OPN is a phospho-pro-
tein  containing  several  calcium  binding
domains  expressed  in  differentiating
osteoblasts. During bone development it regu-
lates cell adhesion, proliferation and extracel-
lular matrix (ECM) mineralization.
12,13 OCN is
the major protein of bone matrix involved in
the  regulation  of  matrix  mineralization.  In
bone tissue OCN is not present in areas of first
crystal formation, but in the mineralised ECM.
This suggests that its role may be to control
the size and speed of crystal formation.
14
DPSCs osteogenic differentiation was previ-
ously described but the expression analysis of
specific markers was carried out mainly by RT-
PCR techniques. This approach does not give
information  about  protein  synthesized  and
secreted  by  differentiating  DPSC  (dDPSC)
during  the  production  of  calcified  ECM.
Protein analysis can elucidate the timing of
synthesis and secretion of specific bone pro-
teins giving further information on the matu-
ration  degree  of  synthesized  ECM.  Only
recently  some  papers  describe  the  use  of
DPSCs to colonize 3D bio-scaffolds in order to
produce implantable devices.
In this study we analyze the osteogenic dif-
ferentiation of DPSCs on 2D surface in order
to give further evidence regarding their differ-
entiation  in  osteoblast-like  cells.  Osteogenic
differentiation was then evaluated by Western
blot  and  immunofluorescence  analysis  of
bone-related proteins. The production of calci-
fied ECM was also verified. In a second step, in
order to obtain a stem cell-bioscaffold complex,
we employ DPSCs to colonize two commercial
3D  scaffolds:  an  experimental  extracellular
matrix preparation (Matrigel™) and a colla-
gen sponge already used in surgery to improve
tissue  regeneration  or  cicatrisation.  DPSCs
seeded  in  these  scaffolds  were  committed
toward  osteogenic  lineage  in  vitro and  the
degree of differentiation and the production of
calcified matrix were then evaluated.
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Materials and Methods
All the materials used in this study are list-
ed in Table 1.
Cell culture
Cells  were  isolated  from  dental  pulp  as
described in a previous study.8 Human dental
pulp was extracted from third molar or perma-
nent teeth of adult subjects (18 and 35 years of
age) after informed consent of patients under-
going  routine  extractions.  Dental  pulp  was
removed from the teeth and then immersed in
a digestive solution (3 mg/mL type I collage-
nase plus 4 mg/mL dispase in α-MEM) for 1 h
at 37°C. Once digested, pulp was dissociated
and  then  filtered  onto  100  ʼm  Falcon  Cell
Strainers  to  obtain  a  cell  suspension.  Cells
were then plated in 25 cm2 flasks and cultured
in culture medium (α-MEM with 20% FBS, 100
ʼM 2P-ascorbic acid, 2 mM L-glutamine, 100
U/mL penicillin, 100 ʼg/mL streptomycin), at
37°C and 5% CO2. Cells obtained from a single
dental pulp were plated at clonal density (1.6
cell/cm2). After 6 days of culture eight cell pop-
ulations were isolated from nodules originated
by single cells. 
Cell sorting
DPSCs were obtained by magnetic cell sort-
ing using MACS® separation kit, according to
the manufacturer instructions. Three succes-
sive sorting were performed by using specific
antibodies against: CD34, a marker of stromal
and haemopoietic pluripotent stem cells;15 c-
Kit, the tirosin-kinase receptor of stem cells
factor;
16 STRO-1, an antigen present in a stro-
mal cell population containing osteogenic pre-
cursors.
17 These primary Abs were detected by
magnetically  labelled  secondary  Abs  (anti-
mouse  IgG,  anti-rabbit  IgG  and  anti-mouse
IgM). For each selection approximately 7ﾥ106
cells were used. Firstly, pulp cell suspension
was sorted by anti-CD34 Ab. CD34
+ cells were
expanded and then sorted by using anti-c-Kit
Ab to obtain a CD34+/c-Kit+ population. In the
same  way  the  CD34+/c-Kit+ population  was
sorted  by  anti-STRO-1  Ab  to  obtain  the
CD34+/c-Kit+/STRO-1+ population, that repre-
sents isolated DPSCs. 
Flow cytometry
The  expression  of  the  CD34,  c-Kit  and
STRO-1  antigens  was  analyzed  by  indirect
staining  using  mouse  anti-CD34  IgG,  rabbit
anti-c-Kit IgG and mouse anti-STRO-1 IgM, fol-
lowed  by  sheep  anti-mouse-FITC,  goat  anti-
rabbit-FITC  and  goat  anti-mouseIgM-FITC.
Non-specific  fluorescence  was  assessed  by
using normal mouse IgG or IgM followed by the
secondary  antibody  as  described  above.
Analyses were performed with a EPICS XL flow
cytometer (Beckman Coulter, Brea, CA, USA).
Osteogenic differentiation in vitro
In  order  to  obtain  a  differentiation  into
osteoblast on 2D surface, DPSCs were seeded
at  approximately  3000  cells/cm2 on  culture
dishes  in  the  osteogenic  medium  (α-MEM,
supplemented with 10% FBS, 100 ʼM 2P-ascor-
bic acid, 2 mM L-glutamine, 100 U/mL peni-
cillin  and  100  ʼg/mL  streptomycin,  100  nM
dexamethasone, 10 mM β-glycerophosphate).
The  medium  was  changed  twice  a  week.
Control  DPSCs  were  cultured  in  the  same
medium without dexamethasone and β-glyc-
erophosphate. For immunofluorescence exper-
iments  DPSCs  were  differentiated  on
Thermanox® plastic coverslips.
Cell counting was performed in control and
in dDPSC of three independent experiments
by a Nikon TE2000 inverted Microscope using
a 10ﾥ objective and differential interference
contrast (DIC). For each experimental point,
the mean of cell number were calculated and
cell density was expressed as cells/cm2.
Matrigel™  (Becton,  Dickinson  and  Co.)
and  collagen  sponge  (Condress®,  Abiogen
Pharma)  were  used  as  3D  scaffolds  in  this
study. Cells were seeded in both scaffolds in an
adequate volume of medium to obtain a start-
ing density of 1000 cell for mm3. For each sam-
ple cells were added to Matrigel™ at 4°C when
it  appears  as  liquid.  A  total  volume  of 
400 ʼL of DPSCs-Matrigel™ was placed in a
12 multiwell plate in order to form a 1 mm
thick  layer  which  was  polymerized  at  37°C.
DPSCs were injected in a 500 mm3 sample col-
lagen sponge by a micropipette tip in different
points to obtain a homogenous cell distribu-
tion.  After  8  h  from  cells  seeding,  2  mL  of
osteogenic medium was added to each sample.
Medium changes were made twice at week.
Western blotting 
Whole cell lysates were obtained from undif-
ferentiated and differentiating DPSCs at dif-
ferent  times  of  culture.  Cells  lysates  were
obtained  as  previously  described.
18 50  ʼg  of
protein (Bradford assay) for each sample were
separated by 10% or 15% SDS page and then
transferred to nitrocellulose membranes. The
protocols of the Western blot were performed
as described by Sambrook et al.
19 Blots were
incubated overnight with one of the following
Abs (diluted 1:1000 in TBS-T + 2% BSA and 3%
milk):  anti-CD34,  anti-c-Kit,  anti-STRO-1,
anti-Runx2, anti-OCN, anti-OPN and anti-Osx.
Membranes were next incubated with peroxi-
dase-labelled anti-rabbit, anti-mouse or anti-
goat secondary Abs diluted 1:5000, for 30 min
at  room  temperature.  All  membranes  were
visualized using ECL (enhanced chemiolumi-
nescence, Amersham, UK). Anti actin Ab was
used as control of protein loading in timing
experiments. 
To detect secreted OCN (sOCN), each sam-
ple was cultured with 2.5 mL of medium. Two
mL of medium were collected for each sample
at the same time-point and then precipitated
in  10%  Trichloroacetic  acid  (TCA).  Pre  -
cipitated proteins were re-suspended in 0.1N
NaOH in H2O and then in Sample Buffer.  The
whole protein amount obtained for each sam-
ple was loaded in the SDS page in order to
have as a unique variable proteins secreted
from dDPSCs.
Densitometry  was  performed  on  Western
blot  (WB)  from  three  independent  experi-
ments by NIS software (Nikon, Tokio, Japan).
An equal area (AOI) was selected inside each
band and the mean of gray levels (in a 0-256
scale) was calculated. Data were then normal-
ized  to  values  of  background  and  of  control
actin band. 
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Table 1. Materials used in the present study.
Material Company
Cell culture reagents, supplements and SIGMA, St. Louis, MO, USA
digestive enzymes; paraformaldehyde,
Glutaraldehyde, BSA, triton and other common 
reagents; anti actin Ab; Durcupan™ ACM Fluka
FBS Euroclone, Milano, Italy
Matrigel™ BD, Franklin Lakes, NJ, USA
Collagen Sponge Condress® Abiogen Pharma, Pisa, Italy
MACS® sorting kit and magnetically  Miltenyi biotech, Bergisch Gladbach, Germany
labelled secondary Abs
Thermanox® coverslips Nalge Nunc International, Naperville, IL, USA
Mouse anti-CD34; anti human type I collagen Millipore Corporation, Boronia, Victoria, AU
Rabbit anti-c-Kit; mouse IgM anti-STRO-1;  Santa Cruz Biotechnology, Santa Cruz, CA, USA
Mouse anti-OPN; 
Rabbit anti-Runx2 Abcam, Cambridge, UK
Rabbit anti-Osx; mouse antiOCN GeneTex, Irvine, CA, USA
Secondaries antibodies Jackson ImmunoResearch, West Grove, PA, USA[European Journal of Histochemistry 2010; 54:e46] [page 215]
Histology
Samples of 2D or 3D cultures were fixed in
4%  Paraformaldehyde  in  phosphate  buffered
saline (PBS) at pH: 7.4 for 15-60 min and then
processed for successive steps. Cells differen-
tiated  on  coverslides  were  processed  for
immunofluorescence or histological staining.
Matrigel samples were in toto processed, while
collagen  samples  were  processed  to  obtain 
10  ʼm  thick  cryosections.  Routine  haema-
toxylin and eosin staining was performed on
some  samples  to  analyze  morphological
details. For Alizarin red staining, fixed cells
(or cryosections) were incubated for 30 min at
room  temperature  in  a  solution  containing
0.1% alizarin red and 1% ammonium hydrox-
ide. Counterstaining with fast green was also
performed to visualize cell morphology. Images
of  histological  samples  were  obtained  by  a
Zeiss  Axiophot  microscope  (Zeiss  AG,  Jena,
Germany),  equipped  with  a  Nikon  DS-5Mc
CCD colour camera. 
Immunofluorescence and confocal
microscopy
Fixed  monolayer  cells  and  in  toto
Matrigel™  samples  were  permeabilized
respectively with 0.1% and 1% Triton X-100 in
PBS for 10 min. Permeabilized samples and
cryosections were then blocked with 3% BSA
in PBS for 30 min at room temperature and
incubated with the primary antibodies diluted
in PBS containing 3% BSA (rabbit anti-c-Kit,
mouse  anti-CD34,  mouse  IgM  anti-STRO-1;
rabbit  anti-Runx2;  mouse  anti-OPN;  rabbit
anti-Osx; mouse anti-OCN) diluted 1:50 for 1 h
at  RT.  After  washing  in  PBS  containing  3%
BSA, the samples were incubated for 1 h at
room  temperature  with  the  secondary  Abs
diluted 1:200 in PBS containing 3% BSA (don-
key anti-rabbit-AMCA; sheep anti-mouse-FITC,
and  goat  anti-mouseIgM-Cy5™;  donkey  anti
rabbit-Cy3™). After washing in PBS, samples
were stained with 1 ʼg/mL DAPI in H2O for 1
min (not performed in samples treated with
donkey anti-rabbit-AMCA Ab) and then mount-
ed with anti-fading medium (0.21 M DABCO
and  90%  glycerol  in  0.02  M  Tris,  pH  8.0).
Negative  controls  consisted  of  samples  not
incubated  with  the  primary  antibody.  The
multi-labelling  immunofluorescence  experi-
ments were carried out avoiding cross-reac-
tions between primary and secondary antibod-
ies.
Fluorescent  samples  were  observed  by  a
Nikon  TE2000  microscope  equipped  with  a
CCD camera Hamamatsu ORCA 285. Images
were captured and processed by NIS software
(Nikon, Tokyo, Japan). Confocal imaging was
performed on a Leica TCS SP2 AOBS confocal
laser-scanning  microscope  as  described  by
Maraldi  et  al.20 The  confocal  serial  sections
were processed with the Leica LCS software to
obtain  three-dimensional  projections.
Projections from each signal were processed
as previously described.21The image rendering
was performed by Adobe Photoshop software.
Electron microscopy
Samples processed for morphology observa-
tions  were  fixed  in  2.5%  glutaraldehyde  in
Phosphate buffer (pH: 7.4) for 1 h and post-
fixed in 1% OsO4 for 1 h. Ultrathin sections,
obtained from Durcupan embedded samples,
were stained with uranyl acetate-lead citrate
and  then  observed  by  with  a  Zeiss  EM109
Transmission Electron Microscope (Zeiss AG,
Jena,  Germany).  Immunogold  experiments
were  performed  as  described  in  a  previous
study.
22 Briefly, samples were fixed in 1% glu-
taraldehyde in Phosphate buffer (pH 7.4) for 1
h, dehydrated in ethyl alcohol (50%, 70%, 90%,
95%  and  100%),  diaphanized  in  propylene
oxide  and  embedded  in  Durcupan  resin.
Human collagen was detected, in ultrathin sec-
tions, by a mouse anti-human type I collagen
Ab  revealed  by  a  10  nm  gold  labelled  anti-
mouse Ab. 
Statistical analysis
Quantitative or semi-quantitative data were
expressed as mean ± standard deviation (SD).
Differences between two experimental points
or  between  experiments  were  evaluated  by
Student's  t-test.  In  all  analyses,  values  of
P<0.05 were considered a significant statisti-
cal  difference,  while  values  of  P<0.01  were
considered a highly significant statistical dif-
ference.
Results
DPSC isolation
The cells obtained from dental pulp by enzy-
matic digestion were cultured for several days
to isolate DPSCs. The eight cell populations
isolated from nodules, as reported in Materials
and methods section, produce calcified matrix
when maintained in osteogenic medium (data
not shown). Flow cytometry analysis of these
cell  populations  (Figure  1A)  shows  that  the
percentages  of  c-Kit+,  CD34+ and  STRO-1+
cells are 64%, 46% and 98% respectively (mean
values), indicating that the majority of nodule
constituting  cells  express  c-Kit,  CD34  and
STRO-1 and then can be considered the SBP-
DPSCs sub-population isolated by Laino et al.
23
To improve the percentage of cells express-
ing c-Kit, CD34 and STRO-1, DPSCs were iso-
lated from other cell types by MACS technolo-
gy. To verify if sorted cells are c-Kit
+, CD34
+
and  STRO-1
+,  flow  cytometry  and  triple
immunofluorescence  experiments  were  per-
formed  on  selected  cells,  by  using  specific
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Figure  1.  DPSCs
selection. A: Diagram
representing the per-
centage  of  c-Kit,
CD34  and  STRO-1
positive cells in eight
different  DPC
colonies derived from
clonal  density  plated
cells. B: Flow cytoflu-
orimetric  analysis  of
DPSCs  sorted  by
MACS.  The  percent-
age of positive cells is
indicated.  C:  Fluore  -
scence  image  of
DPSCs triple labelled
by  anti  c-Kit  (Blue),
anti-CD34  (green)
and  anti-STRO-1
(Red) Abs. Scale bar:
10  ʼm.  D:  Western
blot analysis of whole
cell  lysates  of  sorted
DPSC  by  anti  c-Kit,
anti-CD34  and  anti-
STRO-1 Abs. Arrows
indicate  the  specific
bands.[page 216] [European Journal of Histochemistry 2010; 54:e46]
antibodies (Figure 1). Flow cytometry demon-
strates that MACS sorting improves the per-
centage of CD34+ (plus 20%) and c-Kit+ (plus
34%) cells (Figure 1B). Immunofluorescence
analysis shows that most of the sorted cells are
simultaneously positive to the three antigens
(Figure 1C: Blue for c-Kit, Green for CD34, Red
for STRO-1). Each positive cell shows a diffuse
labelling on the plasma membrane with the
three  signals  appearing  mostly  as  separate
pixels and without overlap or co-localization.
Only a small number of spots show the co-pres-
ence of two signals probably due to clusteriza-
tion of receptors. The Ab specificity was con-
firmed by WB experiments (Figure 1D).
Osteogenic differentiation on 2D
surface
In  order  to  obtain  osteogenic  differentia-
tion, DPSCs were plated on a plastic surface at
the density of 3000 cell/cm2 and then cultured
in  osteogenic  medium  for  up  to  40  days.
Osteogenic  differentiation  was  evaluated  by
morphological, biochemical and immunocyto-
chemical methods. DPSCs treated with culture
medium alone represented control cells. 
The  differentiating  cultures  and  control
cells  were  observed  by  phase  contrast
microscopy  to  evaluate  the  morphological
changes and the proliferation rate (Figure 2).
Seeded cells show a fibroblast-like morphology
(Figure 2A), proliferate and reach the conflu-
ence as monolayer at day 8 in both differenti-
ating and control cultures. At this time dDPSC
(Figure 2E) show a lower cell density and pres-
ent a more extended cytoplasm (Figure 2B).
After day 8 control cells proliferate actively and
form overlapped layers that become evident at
days 24 and 40 (Figure 2 C,D). On the contrary,
differentiated  cells  are  characterized  by  a
lower proliferation activity and start to form
nodular aggregates at day 24 (Figure 2F and
inset).  At  day  40,  in  differentiated  cultures,
mineral  deposits  appear  in  the  extracellular
space and in nodular aggregates (Figure  2 G,
H). Cell counting indicates that both differen-
tiating and control cells present the same pro-
liferation rate until day 8. Then undifferentiat-
ed DPSCs continue to grow exponentially and
at  day  40  reach  a  density  of  over  150,000
cells/cm2. On the contrary differentiating cells
show a lower proliferation activity until day 24.
After this time the number of dDPSC slightly
decreases (Figure 2I).  
To verify the commitment and differentia-
tion  of  DPSCs  into  osteoblast-like  cells,  the
presence of specific markers, such as Runx2,
Osx, OPN and OCN, was analyzed by WB in
whole cell lysates of dDPSC. A densitometric
analysis was carried out on the WB bands to
obtain a semi-quantitative analysis of the pro-
tein  amount  (Figure  3  A,B).  Runx2  is
detectable in all the experimental time points
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Figure 2. Growth dynam-
ics of undifferentiated and
dDPSC.  Phase  contrast
images  of  control  DPSCs
grown in culture medium
alone  at  0  (A),  8  (B),  24
(C)  and  40  (D)  days  or
maintained  in  osteogenic
medium for 8 (E), 24 (F)
and 40 (G, H) days. Scale
bar:  200  ʼm.  I:  diagram
representing the prolifera-
tion rate of both undiffer-
entiated and dDPSC. Data
were  calculated  by  three
independent  experiments
and presented as the mean
±SD  of  cell  number  for
cm2. *P<0.01.
Figure 3. Expression pattern of dDPSC. Western
blot (WB) analysis (A) and densitometry (B) of
Runx2, Osx, OPN and OCN expression in whole
lysates of DPSCs at different time points of cul-
ture.  Actin  bands  demonstrate  that  an  equal
amount of protein was loaded in each line. C: WB
and  densitometry  of  OCN  released  in  culture
medium. Values, calculated on three independent
experiments, are expressed as mean (±SD) of gray
levels of a 0-256 scale. *P<0.01; §P<0.05.[European Journal of Histochemistry 2010; 54:e46] [page 217]
but presents significant expression peaks. The
two major peaks occur at days 8-16, indicating
the starting of DPSCs differentiation, and a
third peak is evident at day 32. Runx2 amount
decreases  at  days  24  and  40  suggesting  a
down-regulation of this protein. Osx is weakly
present at day 16 and then increases showing
two expression peaks at days 24-32, while at
day  40  the  protein  level  slightly  decreases.
OPN is expressed from day 8 to the end of the
experiment, reaching an expression peak at
day 16 and decreasing progressively until day
40. OCN is detectable during DPSC osteogenic
differentiation both in cell lysates and in cul-
ture  medium,  as  secreted  protein  (sOCN).
This  protein  is  significantly  expressed  in
whole lysates from day 16 and shows a peak at
day  40  (Figure  3  A,B).  In  culture  medium,
sOCN starts to be present at day 16, increases
at day 24, then decreases at day 32 and reach-
es the highest level at day 40 (Figure 3C). 
Western blot experiments were confirmed
by  immunofluorescence  analysis.  Double
immunofluorescence labelling was carried out
to analyze simultaneously the localization of
OPN and Runx2 in dDPSC (Figure 4 A,F). The
distribution of OCN and Osx (Figure 4 G,L)
was  observed  in  the  same  manner.  During
DPSCs osteogenic differentiation OPN is local-
ized in the cytoplasm, above all in the perinu-
clear region that normally contains the RER
(Figure 4 A,C,E; green signal). Runx2 is local-
ized in the cell nucleus, as demonstrated by
the  overlapping  with  DAPI  signal,  and  the
nucleoplasmic distribution typical of transcrip-
tion factors can be observed (Figure 4 B,D,F
and insets; DAPI, blue signal; Runx2, red sig-
nal). At day 8 it is present approximately in all
cell  nuclei,  while  at  day  24,  when  a  strong
decrease  was  observed  by  WB,  it  is  mainly
expressed in nodular aggregates, and nuclei of
monolayered cells show a lower labelling. At
day  40  Runx-2  appears  heterogenically
expressed  at  low  levels  only  by  some  cells
(Figure  4  A,F;  red  signal).  Immunofluo  -
rescence  analysis  using  anti-OCN  and  anti-
Osx Abs also confirm WB data. OCN shows typ-
ical  cytoplasmic  localization  with  a  pattern
compatible  with  the  distribution  of  RER
(Figure  4  G,I,K,  green  signal).  Similarly  to
Runx2, Osx shows a nucleoplasmic localiza-
tion (Figure 4 H,J,L and insets). It is interest-
ing to note that the signals from two proteins
increase  significantly  at  days  24  and  40
(Figure 4 I,L) and that nodular aggregates are
more labelled than cells of surrounding mono-
layer (Figure 4 I,J). At day 41 we observe sig-
nificant changes of cell morphology with evi-
dent cellular process typical of differentiating
osteoblasts (Figure 4 E,K).
In order to verify if dDPSC are able to pro-
duce calcified matrix, cells were stained with
alizarin  red  and  counterstained  with  fast
green, to evidence cell morphology. The pres-
ence  of  calcium  deposits  becomes  evident
after 40 days of culture (Figure 4 M,N) when
nodular  aggregates  appear  stained  in
red/orange. It is interesting to note that cells
entrapped in calcium deposits show an osteo-
cyte-like morphology (Figure 4M and inset).
Osteogenic differentiation on 3D
scaffolds
To  evaluate  DPSCs  differentiation  in  3D
scaffolds, cells were cultured and differentiat-
ed in two commercial devices: i) BD Matrigel,
a solubilized extracellular matrix preparation
extracted  from  the  Engelbreth-Holm-Swarm
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Figure  4.  Immuno  fluo  -
rescence  and  histochemi-
cal analysis of dDPSC. A-
F:  Triple  fluorescence
images  showing  signals
from  anti-OPN  (green),
anti-Runx2  (Red)  and
DAPI (Blue) of dDPSC at
8 (A,B), 24 (C,D) and 40
(E,F) days of culture. The
superimposing  between
OPN and Runx2 signals is
given in A, C, E while the
overlap  between  Runx2
and DAPI signals is given
in B, D, F and insets (3x
magnification respect to B,
D and F). G-L: Triple fluo-
rescence  images  showing
signals  from  anti-OCN
(green),  anti-Osx  (Red)
and  DAPI  (Blue)  of
dDPSC  at  8  (G,H),  24
(I,J) and 40 (K,L) days of
culture.  The  superimpos-
ing between OCN and Osx
signals is given in G, I, K
while the overlap between
Osx  and  DAPI  signals  is
given in H, J, L and insets
(3x  magnification  respect
to  H,  J  and  L).  M-N:
images of 40 days cultured
DPSCs  stained  with
Alizarin  red  and  Fast
Green (inset in M is a 2x
magnification  respect  to
M). Scale bar: 20 ʼm.[page 218] [European Journal of Histochemistry 2010; 54:e46]
(EHS) mouse sarcoma; ii) Collagen Sponge, a
biomaterial made of insoluble equine type I
collagen, already used in clinical practice as
scaffold  to  support  bone  regeneration.  Cells
were seeded in both scaffolds at the density of
1000 cell/mm3 and treated for osteogenic dif-
ferentiation for up to 40 days. Cell growth and
osteogenic  differentiation  were  evaluated  at
day 40, by histological, immunocytochemical
and ultrastructural methods.
DPSCs seeded into Matrigel appear distrib-
uted in all the volume of the sample, they grow
actively during the first week and form numer-
ous  cellular  aggregates  distributed  homoge-
neously throughout the culture plate (Figure
5A). Each cellular aggregate, composed of cells
with  spindly-type  morphology,  shows  a  core
with a higher cell density than the marginal
area. The peripheral cells are in contact with
cells of the near aggregates and probably inter-
act, forming a cellular network (Figure 5B).
Confocal  analysis  of  immunofluorescence
experiments with anti-OPN and anti-OCN Abs
shows that cells of nodular aggregates express
the  two  proteins  after  40  days  of  culture
(Figure 5 C,D) indicating that DPSCs are dif-
ferentiating  in  osteogenic  lineage.  The
alizarin staining of 40-day samples shows that
nodular aggregates contain calcium deposits
localized  in  the  matrix  close  to  the  cells
(Figure 5 E,F). TEM analysis of dDPSC cul-
tured in Matrigel demonstrates that peripheral
cells of nodular aggregates are connected by
junctions  probably  classifiable  as  gap-type
(Figure 5 G,H).
H&E  staining  shows  that  DPSCs  colonize
collagen scaffold, penetrating into the sponge
and  proliferating  three-dimensionally.  Cells
are  not  homogeneously  distributed  in  the
sponge thickness, showing a higher cell densi-
ty in the superficial layer, that decreases pro-
gressively  towards  the  centre  of  the  sponge
(Figure 5I). Superficial cells have a flattened
morphology and form a thin compact layer of 4-
5 cells. Cell morphology changes from the sur-
face to the sponge centre and becomes pro-
gressively  spindle-type  with  the  cellular
process  typical  of  differentiating  osteoblasts
(Figure 5J). In the sponge aggregates of colla-
gen  fibres  are  visible,  surrounded  by  cells
resembling trabecular-like structures (Figure
5 I,J arrows).  
Immunocytochemical  evaluation  of
osteogenic differentiation shows that DPSCs
growing in collagen sponge express both OPN
and OCN osteogenic markers. OPN is strongly
expressed  by  DPSCs  localized  in  superficial
layers and is less present in the inner ones
(Figure  5K).  Cells  positive  to  OPN  Ab  are
strictly adherent to collagen fibres associated
in trabecular-like structures, as also observed
by H&E staining (arrows). DPSCs localized in
inner layer, presenting an osteoblast-like mor-
phology or localized near trabecular-like struc-
tures,  express  higher  levels  of  OCN  with
respect to superficial cells (Figure 5L). 
Alizarin  Red  staining  shows  that  calcium
deposits  are  present  in  the  whole  sponge
thickness  and  much  more  in  trabecular-like
structures (Figure 5 M,N). 
TEM analysis of dDPSC cultured in collagen
sponge demonstrates that cells are inter-con-
nected  by  gap  junction  as  described  for
Matrigel (not shown). The assembling of neo-
synthesized tropo-collagen molecules in colla-
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Figure 5. Microscopical analy-
sis  of  DPSCs  cultured  in  3D
scaffolds. A-H: In toto images
of a 1 mm thick Matrigel layer
in which DPSCs was cultured
for  40  days.  Stereomicro  -
scopical images are shown in A
and B. Confocal images of flu-
orescence  signals  from  anti-
OPN  and  anti-OCN  Abs
superimposed with DAPI sig-
nal  are  given  in  C  and  D
respectively.  Alizarin  Red
staining is shown in E and F.
TEM images of a probable gap
junction between two dDPSC
is shown in G-H (H represent a
magnification  of  G).  I-N:  10
ʼm  thick  cryosections  images
of Collagen scaffolds colonized
with dDPSC. H&E images are
shown  in  I  and  J.  Confocal
images of fluorescence signals
from anti-OPN and anti-OCN
Abs superimposed with DAPI
signal  are  given  in  K  and  L
respectively.  Arrows  in  I-K
indicate  a  trabecular-like
structure surrounded by cells.
Alizarin Red staining is shown
in M and N. A-B: scale bar: 2
mm.  C-F  and  I-N:  scale  bar:
100  ʼm.  G-H:  scale  bar:  0.5
ʼm.[European Journal of Histochemistry 2010; 54:e46] [page 219]
gen sub-microscopic fibrils is well visible both
in sagittal and in transversal sections (Figure
6 A,B). To verify if sub-microscopic fibrils are
effectively  secreted  by  dDPSC,  immunogold
experiments with anti Human collagen I Ab
were carried out. This Ab recognizes collagen I
of Human origin but it does not react with the
equine type I collagen of the sponge (Figure 6
C,D).  Immunogold  experiments  demonstrate
that sub-microscopic fibrils are clearly labelled
by  anti-Human  collagen  I  Ab  (Figure  6D,
arrows).  On  the  opposite,  equine  collagen
fibres of the sponge are not labelled by anti
Human collagen I Ab (Figure 6D, arrow head).
Discussion
In this study we analyze the osteogenic dif-
ferentiation  features  of  DPSCs  in  vitro cul-
tured  on  2D  surface  and  in  3D  scaffolds.
DPSCs population isolated from dental pulp of
adults’ teeth present in their membrane the c-
Kit, CD34 and STRO-1 antigens and then coin-
cides  with  the  DPSC  sub-population  (SBP-
DPSCs) described by Laino et al.23 According to
data previously described, osteogenic differen-
tiation of DPSCs was obtained by treatment
with dexamethasone to stimulate cell differen-
tiation, ascorbic acid to stimulate extracellular
matrix  synthesis  and  β-glycerophosphate  to
promotes  ECM  mineralization.4,24 DPSCs
respond  to  this  osteogenic  condition  with  a
strong decrease of proliferation after day 8 of
culture,  when  the  confluence  was  reached.
After this point control cells proliferate active-
ly  forming  overlapped  layers  while  dDPSC
grow as monolayer and form typical mineral
deposits  and  nodules  described  by  other
authors.23 After day 24, the number of dDPSC
shows  a  slightly  reduction  probably  due  to
increase of cell death that normally occur dur-
ing late cell differentiation. 
To verify if morphological observation really
indicates  a  DPSC  osteogenic  differentiation
we investigated in dDPSC the expression of
bone  related  proteins.  Recently  Yu  and  co-
workers  demonstrated  that  STRO-1+ DPSCs
can only differentiate in osteogenic lineage,
after  the  9th  passage,  expressing  specific
markers.25 Different transcription factors and
proteins  typical  of  bone  ECM  are  expressed
during osteoblast differentiation. Only a small
number  of  these  can  be  used  as  stringent
markers because they are clearly expressed in
bone tissue or show typical expression peaks
during osteoblast differentiation. The DPSCs
osteogenic  differentiation  observed  in  our
experiments can be distinguished in two phas-
es on the basis of expression of specific mark-
ers like Runx2, Osx, OPN and OCN. The first
phase from day 0 to day 16 is characterized by
a strong expression of Runx2 coupled with a
greater  presence  of  OPN.  Runx2  is  in  fact
expressed in undifferentiated cells but shows
a  considerable  increase  between  8  and  16
days,  that  coincides  with  the  proliferation
decrease and presumably with the starting of a
late differentiation phase. OPN shows its max-
imum  expression  level  at  day  16  in  coinci-
dence  with  Runx2  peak  and  then  decreases
progressively  to  the  end  of  culture.  These
observations  indicate  that  this  phase  repre-
sents an early stage of osteogenic differentia-
tion according to data that describes high lev-
els  of  Runx2  and  OPN  in  immature  osteo -
blasts.
26 The proliferation decrease observed in
this early phase is consistent with the role of
Runx2  that  acts  as  a  negative  modulator  of
osteoblast proliferation.
27 In the second phase,
from day 16 to day 40, dDPSC show a low pro-
liferation rate and express a higher amount of
Osx maintained until day 32. The increase of
Osx occurring after Runx2 peaks is consistent
with data describing Osx positively, governed
by Runx2 during osteoblast differentiation.
10,26
In this phase the regular increase of intracel-
lular OCN levels and the marked presence of
sOCN in culture medium indicate that dDPSCs
undergo a late differentiation phase character-
ized by an ECM maturation process. Previous
data indicate that OCN is the most specific
marker  of  late  osteoblast  differentiation
because  it  is  synthesized  only  by  mature
osteoblasts  at  the  end  of  matrix  maturation
process.
28,29 The OPN decrease observed in this
phase was supported by observations demon-
strating the presence of OPN during osteoblast
differentiation and its progressive down-regu-
lation according to its role of mineralization
inhibitor.
24,30 In our model, after the first induc-
tion, started by the first Runx2 peaks, other
osteogenic inductions can be promoted by fol-
lowing Runx2 peaks in order to maintain an
immature  sub-population  of  dDPSC  that
undergo  further  terminal  differentiation
events.  On  the  other  hand  immunofluores-
cence  data  indicate  that  the  decrease  of
Runx2, observed by WB at day 24, occurs in the
majority  of  dDPSCs  while  its  expression  is
maintained in cells of nodular aggregates. In
contrast Osx and OCN at day 24 are expressed
both in nodular aggregates and in monolayer
cells.  Successively  their  presence  character-
izes  almost  the  entire  cell  population.  This
data suggest that nodular aggregates are con-
temporaneously composed of a sub-population
of immature dDPSC and by a dDPSC popula-
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Figure  6.  Ultrastructural  analysis  of  DPSCs  cultured  in  Collagen  scaffolds.  A-B:
Morphological features of dDPSC in collagen sponge; tropocollagen assembling is shown
in A (sagittal section of sub-microscopic fibrils) and B (transversal section of sub-micro-
scopic fibrils). C-D: Immuno-gold analysis of dDPSC by anti-Human Collagen I Ab. D
represents a magnification of C. In D arrows indicate sub-microscopic fibrils labelled by
anti anti-Human Collagen I Ab (gold particles); arrow head indicates equine collagen
fibres of the sponge not labelled by immunogold reaction. Scale bar: 0.5 ʼm.[page 220] [European Journal of Histochemistry 2010; 54:e46]
tion that progressively undergo to terminal dif-
ferentiation. The change of cell morphology at
day 40, characterized by thin and long cellular
process, indicates that dDPSCs are in a very
late differentiation phase. Moreover, Alizarin
Red staining demonstrates that calcified ECM
was produced and in some cases dDPSCs are
entrapped by this and show osteocyte-like mor-
phology. 
An  optimal  bone  formation  requires  that
osteoblasts grow and differentiate in a three-
dimensional (3D) environment, allowing the
formation  of  an  intercellular  network.
Previous studies indicate that osteogenic dif-
ferentiation is improved by culture in 3D scaf-
folds that mime the physiological condition.
31-33
Calcified tissue can be produced in vitro using
bone marrow MSC cultured on collagen sponge
or similar bio-scaffolds, already utilized in sur-
gery to support and improve bone regenera-
tion.
34-37 Our data obtained by culturing DPSCs
on Matrigel™ and Collagen sponge indicate
that  both  scaffolds  optimize  DPSCs  growing
and differentiation. The gelatinous structure
of Matrigel mimes the amorphous extracellu-
lar  matrix  components  (proteoglycans  and
GAG) and allows DPSC to grow forming three-
dimensional  nodules.  TEM  analysis  demon-
strates that peripheral cells of these nodules
are interconnected by gap junction analogous-
ly to osteocyte network observed in bone tis-
sue.
38,39 A better result was obtained with colla-
gen sponge because DPSCs colonize this scaf-
fold with a distribution that mimes the bone
histology. Cells of superficial layers are less
differentiated  as  demonstrated  by  the  clear
expression of OPN that decreases in the inner
layers. Moreover these cells present a very flat
morphology and form a thin superficial layer
that can be compared with the bone perios-
teum.  Cells  with  osteoblast-like  morphology
that, unlike superficial cells, express high lev-
els of OCN (late differentiation marker) and
actively  neo-synthesize  human  collagen,  are
present  in  the  inner  layers.  In  this  region
structures  containing  dense  collagen  fibres
and calcified matrix that resemble bone tra-
beculae, were detectable. 
In this study we demonstrated that DPSCs
are able to differentiate in osteogenic lineage
both  in  2D  and  3D  surfaces,  creating
osteoblast-like  cells  that  express  specific
osteogenic markers and produce mineralized
ECM.  The  combination  with  3D  bioscaffolds
was performed in order to produce a dDPSC-
bioscaffold device that can be easily inserted
by the surgeon during surgical intervention in
order to repair any bone tissue deficiency. This
tissue engineering approach could be a prom-
ising tool to restore bone defects and deficien-
cies  that  currently  are  treated  surgically
through the application of artificial permanent
implants. In particular the in vitro bone pro-
duction from stem cells may represent a radi-
cal breakthrough in the treatment of congeni-
tal or acquired pathologies and secondary trau-
mas  characterized  by  critical  bone  mass
defects, which even today resist any medical or
surgical solution. In addition DPSCs can also
be used to colonize prosthesis and orthodontic
implants in order to optimize the osteo-inte-
gration and the efficiency of the implant itself. 
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